At this year’s PDA Universe of Pre-filled Syringes & Injection Devices, SHL will be showcasing both new technologies and time-tested solutions at two locations – Booth #411 and Table Top #1.
As a forward-looking company with extensive knowledge and experience in the area of drug delivery devices, SHL delivers solutions for today on the path to tomorrow.
A prime example of this is the innovative auto injector platform – Molly®. Molly® plays a central role to both SHL and our biotechnology/pharmaceutical partners with its patient-friendly design and inherent flexibility, meeting the tough requirements of an innovative auto injector. In addition to Molly®, a wide range of SHL devices will be available for demonstration. SHL representatives will be happy to discuss these devices along with the other services and capabilities available through our comprehensive network, including development, manufacturing and commercialization solutions.
At the conference, Markus Bauss, Managing Director of SHL Connect, will provide a presentation on the topic of “Connectivity in Drug Delivery & Smart Administration.” Here, SHL will present pioneering technological solutions and new partnerships and Joint Ventures in areas of digital health, connected technology and therapy management at the Table Top location.
The conference and exhibition will take place on October 17-18, 2016 at the Hyatt Regency Huntington Beach Resort and Spa, Huntington Beach, California. Visit us at Booth #411 and Table Top #1 to learn more about the Molly Family and other innovative auto injector devices, to find out about our Connectivity solutions and to share ideas about the latest trends in the industry.
SHL is one of the world’s largest solution providers in design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
With over 3,500 staff worldwide, our organization consists of several distinct group companies:
SHL Medical Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl-group.com or contact us at email@example.com